API
< Back to all clusters
[HEALTH] · United Kingdom · 6 sources

started · updated

University of Cambridge researchers develop mRNA therapy to repair heart muscle

Scientists at the University of Cambridge have developed an experimental mRNA therapy designed to stimulate the regeneration of heart muscle cells. The treatment aims to address heart failure by reawakening the ability of cardiac cells to divide and repair damaged tissue, a process that typically ceases after childhood.

In studies conducted on mice following a heart attack, the therapy was injected directly into the heart to temporarily activate two specific proteins: Myc and Cyclin T1. The results, published in Nature Cardiovascular Research, showed that the treated mice experienced a stronger heartbeat and a 10% increase in the amount of blood pumped with each contraction compared to a control group. These improvements were sustained through 12 weeks of observation.

While current medical treatments can manage symptoms and slow the progression of heart disease, they cannot replace muscle lost to scarring or infarction. Dr. Catherine Wilson, a co-senior author from the University of Cambridge, noted that this approach could potentially improve the quality of life for millions of people worldwide. The research team has received funding from the British Heart Foundation to refine the treatment, with future steps involving trials in larger animal models and eventually humans.

Entities

British Heart Foundation · Catherine Wilson · Gurdon Institute · Nature Cardiovascular Research · University of Cambridge